Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

282
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
282
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

60
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
60
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

45
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
45
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

597
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
597

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effects of Long-Term Fertilization Regimes on Crop Yield Stability and Grain Quality in Maize and Winter Wheat Rotation of Northern China.

Plants (Basel, Switzerland)·2026
Same author

Impacts of climate change on greenhouse gas emissions from wastewater: a critical review.

Bioresource technology·2026
Same author

Acute cerebral infarction caused by severe anaphylactic shock: A case report.

Journal of anesthesia and translational medicine·2026
Same author

Border-Associated Macrophages in CNS Health and Disease: A Comprehensive Review of Ontogeny, Heterogeneity, and Functional Plasticity at Neural Interfaces.

ASN neuro·2026
Same author

Baicalein activates the type I interferon signaling pathway to inhibit infectious bronchitis virus infection.

Poultry science·2026
Same author

Stabilizing O3-type layered oxide cathodes <i>via</i> dual-site co-doping for long-life sodium-ion batteries.

Chemical science·2026

相关实验视频

Updated: Jun 7, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.7K

一个基于贝叶斯动态模型的适应性设计,用于在I/II期临床试验中的瘤学剂量优化.

Yingjie Qiu1,2, Mingyue Li1

  • 1Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Pharmaceutical statistics
|November 11, 2024
PubMed
概括

项目Optimus旨在改革化疗剂量. 本研究介绍了瘤学试验的贝叶斯适应性设计,将毒性和疗效结合起来,以确定最佳剂量 (OD) 并改善药物开发.

关键词:
贝叶斯的方法 贝叶斯的方法第I/II阶段试验试验适应性设计是适应性的设计.延迟的结果延迟的结果模型选择,模型选择.最佳的剂量是最优的剂量.

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K

相关实验视频

Last Updated: Jun 7, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.7K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K
Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.2K

科学领域:

  • 瘤学 药物开发 药物开发
  • 临床试验设计 临床试验设计
  • 生物统计学 生物统计学

背景情况:

  • 传统的"更多是更好的"化疗剂量模式已经过时,新的向疗法和抗体-药物联合体 (ADC) 已经过时.
  • 美国食品和药物管理局 (FDA) 启动了"最佳项目",以解决瘤药物开发中的剂量优化和选择问题.
  • 早期瘤学试验面临的挑战是由于数据的变化和刚性参数模型.

研究的目的:

  • 开发一种新的自适应性临床试验设计,以优化早期瘤学研究中的剂量选择.
  • 为了同时纳入毒性和疗效数据,以进行可靠的最佳剂量 (OD) 识别.
  • 提高设计的适应性,以延迟毒性和疗效的结果.

主要方法:

  • 利用贝叶斯动态模型,以最小的假设,利用不同剂量水平的信息.
  • 采用贝叶斯模型的平均值来管理剂量反应关系中的不确定性.
  • 在I/II期试验中开发了一种结合毒性和疗效的适应性设计,用于在I/II期试验中选择最佳剂量.

主要成果:

  • 拟议的贝叶斯适应设计在各种模拟场景中展示了可取的操作特征.
  • 该方法有效地整合了毒性和疗效数据,以进行可靠的最佳剂量识别.
  • 该设计被证明可以适应涉及延迟毒性和疗效结果的场景.

结论:

  • 建议的贝叶斯适应设计为瘤学药物开发中的最佳剂量选择提供了强大而灵活的方法.
  • 这种方法解决了传统剂量模式的局限性,并支持了 Project Optimus 的目标.
  • 该设计为I/II期瘤学试验提供了实际框架,如试验示例所示.